Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $10.3 million.

  • LifeStance Health's Capital Expenditures rose 10374.18% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 1812.66%. This contributed to the annual value of $21.6 million for FY2024, which is 4677.69% down from last year.
  • LifeStance Health's Capital Expenditures amounted to $10.3 million in Q3 2025, which was up 10374.18% from $7.8 million recorded in Q2 2025.
  • LifeStance Health's Capital Expenditures' 5-year high stood at $38.7 million during Q4 2021, with a 5-year trough of $5.1 million in Q3 2024.
  • Its 5-year average for Capital Expenditures is $12.7 million, with a median of $10.3 million in 2025.
  • The largest annual percentage gain for LifeStance Health's Capital Expenditures in the last 5 years was 15187.26% (2022), contrasted with its biggest fall of 7315.2% (2022).
  • LifeStance Health's Capital Expenditures (Quarter) stood at $38.7 million in 2021, then plummeted by 73.15% to $10.4 million in 2022, then grew by 9.92% to $11.4 million in 2023, then plummeted by 44.8% to $6.3 million in 2024, then surged by 63.32% to $10.3 million in 2025.
  • Its Capital Expenditures stands at $10.3 million for Q3 2025, versus $7.8 million for Q2 2025 and $7.2 million for Q1 2025.